RUNX1 and leukemia: In summary, isothermal titration calorimetry (ITC) investigation of DNA-binding ability of the WT and clinical mutations of RUNX1 quantitatively confirms results from earlier research [21,23–26], showing that DNA-binding of the leukemia-relevant mutant RUNX1 is significantly decreased or lost.